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Extramitohondrial mtDNAIn mammalian cells, mitochondria are the only organelles besides the nucleus that house genomic DNA.
The mammalian mitochondrial genome is represented by prokaryotic-type, circular, highly compacted DNA
molecules. Today, more than a half-century after their discovery, the biology of these small and redundant
molecules remains much less understood than that of their nuclear counterparts. One peculiarity of the
mitochondrial genome that emerged in recent years is its disposable nature, as evidenced by cells abandoning
a fraction of their mitochondrial DNA (mtDNA) in response to various stimuli with little or no physiological
consequence. Here, we review some recent developments in the ﬁeld of mtDNA biology and discuss emerging
questions on the disposability and indispensability of mtDNA.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
In mammalian cells, mitochondria are cellular organelles that
generate the bulk of ATP required to sustain a plethora of diverse
cellular processes. Besides generating ATP, mitochondria also play
important roles in intracellular calcium signaling, apoptosis, reactive
oxygen species (ROS) production and detoxiﬁcation, and biosynthesis
of heme and iron–sulfur clusters.
Mitochondria are encapsulated by twomembraneswhich create four
compartments: 1) the outer membrane, 2) the intermembrane space,
3) the inner membrane and 4) the matrix. The inner mitochondrial
membrane houses ﬁve complexes of the oxidative phosphorylation
(OXPHOS) system, of which complexes I–IV comprise an electron trans-
port (respiratory) chain. The mitochondrial matrix houses numerous
anabolic and catabolic enzymes, most prominently enzymes involved
in the Krebs cycle and β-oxidation of fatty acids. The matrix is also the
compartment that houses mitochondrial DNA (mtDNA).
In humans, mtDNA is a circular 16,569 bp molecule (Fig. 1) which
encodes 37 “formal” genes: 13 polypeptides and 24 RNA components
of the mitochondrial translational apparatus (2 rRNAs and 22 tRNAs).
mtDNA is characterized by a tight packaging of genetic information:
mitochondrial genes inmammals lack introns, and intergenic sequences
are either absent or limited to a few bases. In some instances, genes
overlap (MTATP8/6 and MTND4L/4), and translational terminationand Neuroscience, University of
L 36688, USA.
. Shokolenko),codons of sixmitochondrial genes are not encoded in themitochondrial
genome, but are completed by the addition of a polyadenine (polyA) tail
to a terminal uracil encoded in mtDNA (thus generating sequence
(UAA)TERAn). At the same time, mtDNA harbors a large ~1100 bp region
that does not code for any genes, a so-called control region, which over-
laps with a D-loop, a ~1000 nucleotide triple-helical region, which is
formed by abortive initiation of replication.
The base distribution between two strands of human mtDNA (44%
vs. 56% purine content, GenBank NC_012920.1) is asymmetric enough
to allow for their separation in denaturing buoyant density gradients
of cesium chloride. It is frequently stated that the ‘Heavy’ (H) strand
encodes the majority of mitochondrial genes (12 polypeptides, 2
rRNAs and 14 tRNAs), and the ‘Light’ (L) strand encodes the rest. This
notation is historical [1], and according to present-day convention
(and the convention used in the original report on the sequence of
human mtDNA [2]), the L-strand is the coding strand for the majority
of mitochondrial genes. All of the mitochondrially encoded polypep-
tides are components of the OXPHOS complexes I (MTND1-6 plus
MTND4L), III (MTCYB), IV (MTCO1-3) and V (MTATP6 and 8). Notably,
all subunits of the mitochondrial complex II, all proteins responsible
for mtDNA replication and repair, as well as all proteins responsible
for transcription and translation of the mitochondrial genome are
encoded in the nucleus.
1.1. Non-canonical mitochondrial genes
In recent years, it became increasingly apparent that in addition to
its 37 “formal” genes, mtDNA may encode short open reading frames
(ORFs) which can be translated into peptides with important biological
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Fig. 1. The map of human mtDNA. The orientation is according to the revised Cambridge
Reference Sequence (rCRS, GenBank NC_012920.1). Black bent arrows designate origins
and direction of new H-strand (OH) and L-strand (OL) synthesis during replication (or,
conversely, origins of L-strand and H-strand replication), respectively. Red bent arrows
designate mitochondrial promoters that transcribe either H-strand (HSP1 and HSP2) or
L-strand (LSP), respectively. Brown arrows: MT-ND1-MT-ND6, NADH dehydrogenase
subunits 1 through 6. Blue arrows: MTCO1-MTCO3, cytochrome oxidase subunits 1
through 3. Black arrows: MT-ATP6 and MT-ATP8, subunits 6 and 8 of the mitochondrial
ATPase, red arrow: MT-CYB, cytochrome b. tRNAs are designated by green letters using
single-letter codes for corresponding amino acids.
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in an unbiased functional screen for clones that protect neuronal cells
from death induced by amyloid precursor protein (APP) mutants,
which are associated with early-onset familial Alzheimer's disease [3].
Humanin is encoded by a 75 bp ORF within the gene for 16S rRNA,
and was independently isolated in a yeast two-hybrid screen as a
partner of the insulin-like growth factor-binding protein-3 (IGFBP-3).
Humanin has since been shown to exert cytoprotective effects against
not only mutant APPs, but also against neuronal cell death induced by
other stimuli such as mutant presenilins 1 and 2, cytotoxic Aβ peptides,
Aβ1-42, Aβ1-43, and Aβ25-35. It has also been shown to protect against
IGFBP-3 induced apoptosis. Another short ORF encoding the 16 amino-
acid-long peptide mitochondrial open reading frame of the 12S rRNA-c
(MOTS-c) has been recently discovered within the gene for mitochon-
drial 12S rRNA. This peptide targets skeletal muscle, and its cellular
actions inhibit the folate cycle and de novo purine biosynthesis, leading
to activation of the AMP-activated protein kinase. MOTS-c treatment
in mice prevented age-dependent and high-fat-diet-induced insulin
resistance, as well as diet-induced obesity [4].
1.2. mtDNA organization
mtDNA in mitochondria is organized into compact structures called
nucleoids. Nucleoids can be visualized by labeling with various DNA
stains, including anti-DNA antibodies, BrdU, or ﬂuorescent intercalators,
such as DAPI and Pico Green followed by microscopy. Therefore, the
number of nucleoids detected per cell (and thus, estimates of the
number of mtDNA molecules per nucleoid) depends on the properties
of the optical system used, such as optical resolution and signal-to-
noise ratio. Thismay explainwhy values formtDNA content of nucleoids
vary greatly in the literature. The lowest reported estimate of 1.45
mtDNA molecules per nucleoid, obtained with the help of the most
advanced microscopy techniques [5], is likely be the most accurate,
although we cannot exclude the possibility that this number is variable
and/or depends on the cell type.Nucleoids are ovoid structures diverse in size with an average diam-
eter of about 100 nm [5,6]. They are associated with the mitochondrial
inner membrane and are often wrapped around cristae or cristae-like
membrane invaginations [6]. Experimental evidence suggests that
there is little, if any, exchange of mtDNA between nucleoids. The pack-
aging density of DNA in mitochondrial nucleoids is greater than that
in the Escherichia coli nucleoid or human nucleus, and is comparable
to the packaging density in the papillomavirus capsid [7]. This high
degree of compaction is achieved with the help of the mitochondrial
transcription factor A (TFAM), a high mobility group (HMG)-box DNA
binding protein with functions in mtDNA packaging, replication and
transcription. This protein binds mtDNA with a footprint of 23 bp or
30 bp [8], and is present in mitochondria in 1000-fold molar excess
with respect to mtDNA molecules, which is sufﬁcient for the complete
coating of mtDNA [5]. TFAM can bind mtDNA speciﬁcally, at the
H-strand promoter 1 (HSP1) and at the L-strand promoter (LSP) pro-
moters to facilitate transcription and replication, and non-speciﬁcally,
all over the mitochondrial genome [9], to induce mtDNA compaction.
mtDNA compaction by TFAM depends on TFAM dimerization, which is
mediated by HMGA domains [10]. Upon both speciﬁc and non-speciﬁc
binding, TFAM imposes a sharp U-turn on its substrate mtDNA, which
is essential for both transcription and packaging [10]. Interestingly,
mitochondrial TFAM is predominantly DNA-bound. The release of
TFAM from complexes with mtDNA is mediated by phosphorylation
on Ser55 and Ser56 by PKA followed by Lon-mediated degradation [11].
1.3. mtDNA replication
Only one replicative DNA polymerase, DNA polymerase γ (PolG),
has been described in mammalian mitochondria. This holoenzyme
mediates both replication and repair of mtDNA, and consists of a large
catalytic subunit and two accessory subunits. The catalytic subunit
possess the polymerase, 3′ → 5′ exonuclease (proofreading), and 5′-
deoxyribose phosphate (dRP) lyase activities, while the accessory
subunits enhance DNA binding and processivity. Also, a novel DNA
polymerase/primase, PrimPol, has been recently identiﬁed inmitochon-
dria. This enzyme is believed to facilitate replication fork progression by
acting as a translesion DNA polymerase or as a speciﬁc DNA primase
reinitiating downstream of lesions that block synthesis during both
mitochondrial and nuclear DNA replication. Unlike PolG−/−, PrimPol−/−
mice are viable indicating accessory role for the enzyme [12].
The mitochondrial replisome consists of PolG, the mitochondrial
single-stranded DNA binding protein (mtSSB), mitochondrial DNA
helicase, topoisomerases and RNaseH [13]. The lack of dedicated
primase, an enzyme that generates an RNA primer for replication, is a
unique feature of mtDNA replication. Instead of being synthesized by
a dedicated enzyme, the primer for H-strand replication is generated
by transcription initiated by mitochondrial RNA polymerase on an
L-strand promoter (see below). Thus, the RNA polymerase serves to
generate not only transcripts, but also the primers needed for mtDNA
replication.
The mode of mtDNA replication remains controversial, and at least
three models of replication have been described (recently reviewed in
[14]). The original asynchronous strand-displacement model suggests
that mtDNA replication is primed by an L-strand transcript. Interaction
of the transcription elongation factor TEFM with POLRMT and the
nascent transcript prevents the generation of replication primers and in-
creases transcription processivity to enable synthesis of a near-genomic
length L-strand transcript. Therefore, TEFM serves as a molecular switch
between replication and transcription [15]. The primer generated at LSP
is extended by the mitochondrial replisome and displaces H-strand over
~70% of mtDNA length. Then H-strand replication exposes the origin of
the L-strand replication (OL), and the synthesis of a new L-strand is initi-
ated in the opposite direction. The asymmetry of strand synthesis leaves
one segregated daughter molecule with an incompletely synthesized
L-strand, called a gapped circle (GpC).
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thought to be a zone of replication initiation within a broad area beyond
theD-loop.Within this zone, both strands are synthesized bidirectionally
as the conventional double-stranded replication forks advance through
continuous synthesis of leading and discontinuous synthesis (through
Okazaki fragments) of lagging strands. However, this model relies on
continuous ligation of Okazaki fragments during lagging strand synthesis
and appears to be inconsistent with recent ﬁndings that 100-fold reduc-
tion inmitochondrial DNA ligase III does not appreciably affect the rate of
mtDNA replication or copy number [16]. A third model is based on the
observation of RNA incorporation throughout the lagging strand
(RITOLS) [17]. According to this model, replication proceeds as in the
strand-displacement model, except that the displaced H-strand is pres-
ent not as single-stranded DNA, but rather as a DNA/RNA hybrid sensi-
tive to RNase H, until it is made duplex by PolG. It is not clear whether
RITOLS serve as primers for Okazaki fragments, but it appears unlikely
due to the low response of mtDNA replication to DNA ligase III (see
above). Recently, it was demonstrated that the in vivo occupancy proﬁle
of mtSSB displays a distinct pattern, with the highest levels of mtSSB
close to the mitochondrial control region and with a gradual decline
towards OriL. This pattern correlates with the replication products
expected for the strand displacement mode of mtDNA synthesis thus
lending strong in vivo support [18].
1.4. mtDNA copy number control
mtDNA is maintained at different copy numbers in different tissues,
the two extremes of this spectrum being mammalian erythrocytes and
sperm which have no mtDNA and ~5 copies of mtDNA per cell [19],
respectively, and oocytes, which may contain N500,000 copies [20]. In
Drosophila, mtDNA is eliminated from the sperm in the male genital
tract prior to fertilization, so that fertilizing sperm may contain no
mtDNA at all [21]. Curiously, human oocyte quality directly correlates
with mtDNA copy number, whereas this correlation is inverse for the
human sperm [20].
It is often overlooked that normal mtDNA copy number in a given
tissue is not a set ﬁgure, but is rather a range. Therefore, in most popu-
lation studies mtDNA copy number in apparently healthy individuals
varies over a 2–10 fold range [22], and mtDNA content between 40
and 150% of the average is considered clinically normal [23]. Apart
from normal variation in mtDNA copy number, mtDNA content can
be altered under various pathologic scenarios. For example, mtDNA
depletion syndromes [24] are associated with a profound loss of
mtDNA, down to as low as 2% of normal [25]. Even though mtDNA
depletion in these patients is frequently associated with perinatal
lethality, long survival has been reported in a 29 year old patient with
76% depletion, who was observed for this condition since early
childhood [26]. Also, a profound (91%) loss of mtDNA in a 47 year old
patient was associated with relatively mild symptoms such as daytime
sleepiness, exercise intolerance, and myalgias in the lower-limb
muscles [27]. Paradoxically, both increased [28] and decreased skeletal
muscle mtDNA content have been reported in patients with mutations
in mitofusin 2 (MFN2). Changes in mtDNA content in tissues of aged
individuals have been widely reported, although the direction of these
changes remains controversial. Some studies report increased mtDNA
copy number in the elderly [29], while others report a decrease and
associate frailty with either lower [30] or higher [31] mtDNA copy
number.
Regulation of mtDNA copy number is complex and remains incom-
pletely understood. Nitric oxide, PGC1α, NCOR1 and their coactivators
havebeen implicated as regulators through their effects onmitochondrial
biogenesis. A systematic analysis in yeast revealed 102 ORFs whose
deletion led to the loss of mtDNA. Remarkably, 55% of those ORFs
were associated with biosynthesis of mitochondrial proteins [32]. In
humans, sex-speciﬁc quantitative trait loci for mtDNA content have
been identiﬁed on chromosomes 1, 2 and 3 [33]. Recently, epigeneticmodiﬁcation of exon 2 of the gene for the catalytic subunit of PolG has
been implicated in mtDNA copy number regulation [34].
1.5. mtDNA repair and abandonment
Mitochondria contain a reduced complement of DNA repair path-
ways as compared to those present in the nucleus (reviewed in [35]).
As mtDNA encodes only 13 out of ~1500 polypeptides that comprise
mitochondria, all components of mtDNA repair machinery are encoded
in the nucleus, translated on cytoplasmic ribosomes, and post-
translationally imported intomitochondria.Mitochondria are proﬁcient
in both short-patch and long-patch subpathways of the Base Excision
Repair (BER) pathway, which is responsible for the repair of oxidative
and alkylating lesions as well as single strand breaks [35]. Importantly,
someoxidized base lesions are repaired inmitochondriamore efﬁciently
than they are in the nucleus [35]. The presence of any other complete
DNA repair pathway in mitochondria has not been demonstrated yet,
although some components of the mismatch repair pathway have
been identiﬁed in these organelles. How, then, do mitochondria cope
with themutagenic effects of DNA lesions that they are unable to repair?
It turns out that in mammalian cells, the high redundancy of mtDNA
enables a unique, mitochondria-speciﬁc pathway for the preservation
of DNA integrity through degradation of damaged molecules. This
pathway is nonspeciﬁc to the type of lesion and is mobilized not only
in response to lesions that mitochondria are unable to repair, but also
in response to the presence of an overwhelming amount of lesions
that mitochondria are normally able to repair in moderate quantities,
such as oxidative lesions [36], abasic sites, or gapped duplexes [37].
The kinetics of this process is different in different cell lines, and in
some cell lines mtDNA loss can be detected as soon as 5–10 min after
challenge with H2O2 [38]. Strikingly, almost no information exists on
the mechanism of induced mtDNA degradation or nucleases involved
in the process, although it appears unlikely that mitophagy can account
for the rapid mtDNA turnover observed in some experiments [38].
1.6. Extramitochondrial mtDNA
Circulating cell-free mtDNA (mtDNAcf) was described in blood
plasma 15 years ago by Zhong et al. [39], and has been suggested to
have prognostic value in cancer, cardiac arrest and severe sepsis
[40,41]. Recently, mtDNAcf emerged as a danger-associated molecular
pattern (DAMP), a major mediator of innate immunity and systemic
inﬂammatory response syndrome (SIRS). Upon tissue damage
(e.g., blunt-force trauma), blood levels of mtDNAcf dramatically
increase leading to toll-like receptor 9 (TLR-9)-mediated neutrophil
activation and systemic inﬂammation [42]. Curiously, there appears to
be discordance between the reported activation of TLR-9 exclusively
by DNA containing unmethylated CpG islands and the well-
documented cytosine methylation in mtDNA, which is mediated by an
organellar isoform of the nuclear methyltransferase DNMT1 [43].
Since both nuclear and mitochondrial CpG islands can be methylated,
one possible explanation for the selective activation of the immune
system by mtDNA is in the greater content of unmethylated CpGs in
mtDNA.
Extramitochondrial mtDNA has also been reported in the cytosol.
Cytosolic release ofmtDNA can bemediated by strong insults like oxida-
tive stress, or by subtle changes like altered compaction ofmitochondrial
nucleoids secondary to TFAM haploinsufﬁciency [44]. This intracellular
release of mtDNA has been implicated in cell-intrinsic innate immune
responses [45,46].
1.7. mtDNA is disposable but indispensable
The prevailing evidence indicates that mtDNA is disposable and has
a limited life span. In unstressed cells and tissues, it turns over with
relatively short half-lives [47]. The substantial variability of mtDNA
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epidemiological studies suggests that, within limits, alterations in
mtDNA copy number do not affect normal mitochondrial function [22,
30,31,48]. In support of this notion, it has been observed that reduced
mtDNA copy number has no major effect on mitochondrial transcript
levels or enzyme activities in various tissues [49,50]. It has also been
shown that some cells can survive after losing their mtDNA. For exam-
ple, in response to stimulation, eosinophils abandon their mtDNA by
catapulting it into extracellular milieu, while remaining viable [51,52].
In response to a heat shock and upon antibody-induced clustering of
GPI-anchored antigens, ciliated protozoa jettison mitochondria out of
the cells without losing viability [53]. In transgenic mice, doxycycline-
induced expression of the mutant UNG1 resulted in hippocampal
mtDNA depletion [54], which was accompanied by relatively mild
behavioral changes such as increased locomotor activity, impaired
cognitive abilities, and lack of anxietylike responses [55]. Lastly, mito-
chondria are normally shed together with enclosed mtDNA by retinal
ganglion cell axons for degradation by surrounding astrocytes [56].
Reversible loss of mtDNA in experimental animals in response to treat-
ments also supports the notion thatmtDNAmolecules are disposable. In
mice, intragastric administration of ethanolwas accompanied by a ~50%
depletion of mtDNA in all organs studied, which reversed 24 h after
discontinuation of treatment [57]. Degradation of mtDNA was also
observed in a rat model of cerebral ischemia/reperfusion [58]. Similarly
to mtDNA levels following depletion induced by intragastric ethanol
administration, mtDNA levels following cerebral ischemia returned
to normal within 24 h of reperfusion [58]. Unaccustomed resistance
exercise can induce up to 32% mtDNA depletion in mouse muscle [59],
whereas prolonged endurance training results in a 50% increase in
mtDNA copy number in human muscle [60]. These examples demon-
strate that a partial mtDNA loss is relatively common in some cells
and tissues and that this loss, at least in some instances, 1) can be
accompanied by eithermild or no consequences and 2) can be transient
and accompanied by compensatory adaptive mtDNA resynthesis.
While the evidence reviewed above suggests that individual mtDNA
molecules are disposable, it does not answer the question of whether or
not mtDNA in general is superﬂuous for cell viability: in other words, is
mtDNA dispensable? For mammalian erythrocytes, which contain no
mtDNA, it is. Also, cultured animal cells can be induced to undergo a
complete loss of mtDNA. The resulting ρ0 cells become auxotrophic,
but retain viability. Interestingly, however, these cells fail to form
tumors in experimental animals unless they capture mtDNA from
surrounding tissues [61]. Yet, successful attempts to induce global
mtDNA loss in multicellular organisms have not been reported. As
noted above, infants with mtDNA depletion syndromes, which are
accompanied by severe loss of mtDNA, usually die in the ﬁrst year of
life. Also, whole-body ablation of TFAM, a protein required for mtDNA
replication, results in severe mtDNA depletion and is embryonically
lethal inmice [62]. These observations suggest thatmtDNA is indispens-
able for the viability of multicellular organisms.
2. Conclusion
More than 50 years of research have led to dramatic progress in
our understanding of mtDNA biology. Our views have evolved from
dismissing the mitochondrial genome as vestigial to appreciating the
key role of mtDNA and its alterations in cellular bioenergetics andmito-
chondrial disease. Yet it appears that mammalian cells have a relaxed
reliance on mtDNA, which is perpetually destroyed and resynthesized.
Under physiological and pathophysiological conditions, the balance
between these two processes can be shifted and restored, often with
mild or no consequences. The absence of a direct correlation between
mtDNA copy number and levels of mitochondrially encoded transcripts
or proteins, which may remain unaltered during mtDNA depletion [49,
50], provides a mechanistic explanation for this relaxed reliance. Yet,
some key questions remain unanswered. What are the triggers andmechanism(s) of mtDNA degradation? What enzymes are involved in
the process? Is mtDNA degraded down to nucleotides, or to oligonucle-
otides? Is degrading mtDNA contained inside mitochondria or released
intra/extracellularly? Does degrading mtDNA contribute to innate
immune responses? These and other questions will be addressed in
the coming years.
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